Alto Predict helps biomedical researchers find and use human cell-based alternatives to animals to advance human-relevant science for better decisions in drug discovery and product development.
We work with assay developers, biomedical researchers, regulators, industry consortia and startups to advance the development and application of these technologies for better, safer products. These alternatives, known as in vitro NAMs or novel alternative methods, range from simple 2-dimensional cell cultures to organoid-based and microphysiological systems (MPS) or organs-on-a-chip.
Alto Predict is creating data products to support easier access to and understanding of these technologies: a catalog of commercially available human in vitro NAMs and a knowledge base to guide the use of reference control compounds in assay qualification.
We are also building a discovery engine using proprietary relational ontologies applied to in vitro data sets from diverse, human-based assays and platforms to support program decisions, predict drug effects, and discover target functions.
Company Details
- Employees
- 1
- Founded
- -
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.altopredict.com
Alto Predict Questions
Alto Predict's website is http://www.altopredict.com
Alto Predict's LinkedIn profile is https://www.linkedin.com/company/alto-predict
Alto Predict has
1 employees.
View email and phone details for 1
employees at Alto Predict.
Alto Predict's industry is
Research Services
Alto Predict's top competitors are
Eurofins Discovery,
Greenfield Pathology Services, Inc.,
Celaid Therapeutics,
Amino Data Ltd,
Speccro,
Cyprotex,
Insitro,
Pienomial,
Datavid,
3d Bio-Tissues.
Alto Predict's categories are Research Services
Alto Predict's founding year is 2017
